Skip to main content

Dr. Dmitriy Stasishin, DO

Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)

  • Medicare participating

At a glance

Years since graduation
7
In the NPI registry since
2019
Medicare patients seen, 2024
141

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2019Medical school: Kansas City University of Med & Biosciences, College of Osteo Med
  • 2019Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Endocrinology, Diabetes & Metabolism Physician primary
    VA license 0102208614

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Endocrinology & Diabetes per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
141
Services billed
424
Patients’ average age
75

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 32 companies reported 96 payments worth $2,376 in total to this clinician.

By company
Novo Nordisk Inc$360
Lilly USA, LLC$207
Madrigal Pharmaceuticals$177
Sequel Med Tech, LLC$148
Boehringer Ingelheim Pharmaceuticals, Inc.$145
Xeris Pharmaceuticals, Inc.$143
Antares Pharma, Inc.$102
Corcept Therapeutics$102
By type
Food and Beverage$2,333
Education$42.50

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 30, 2025Mannkind Corporation
Sep 30, 2025
Education
AFREZZA · DIABETES MEDICINE · in-kind
$42.50

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Virginia →

Other Endocrinology & Diabetes clinicians in Falls Church

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 26, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1548723281. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.